| Gastroenterology Journal Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Nitazoxanide 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 420
|
Migraine Headache Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 237
|
Nifedipine, Lidocaine, and Nitroglycerin Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 238
|
Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90%
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 145
|
Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
|
Jan/Feb 2023
Pg. 6-10
|
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 513
|
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera, Thompson Tara
|
Sep/Oct 2022
Pg. 378-384
|
Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 429
|
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
|
May/Jun 2022
Pg. 214-217
|
Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 143
|
Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 144
|
Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 500
|
Kayexalate in Lactulose
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 501
|
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 322
|
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 319
|
Dexamethasone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 225
|
Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary
Allen Loyd V Jr
|
May/Jun 2020
Pg. 232
|
Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 132
|
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
|
Mar/Apr 2020
Pg. 140-147
|
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
|
Mar/Apr 2020
Pg. 168-175
|
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 55
|
Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 56
|
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 60
|
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 490
|
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 493
|
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
|
Nov/Dec 2019
Pg. 504-510
|
Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
|
Sep/Oct 2019
Pg. 376-381
|
Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 409
|
Domperidone 5 mg/mL in Oral Mix
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 316
|
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 231
|
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 234
|
Calculations
Stockton Shelly J, Drinnon Stephen D
|
Mar/Apr 2019
Pg. 144
|
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 58
|
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A
|
Jan/Feb 2019
Pg. 70-76
|
Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension
|
May/Jun 2018
Pg. 263
|
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 151
|
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients
McElhiney Linda F
|
Jan/Feb 2018
Pg. 30-39
|
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 55
|
Ranitidine 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 56
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George, Powers Dan, Yeung Stanley, Chen Frank
|
Jan/Feb 2018
Pg. 76-85
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
|
Jan/Feb 2018
Pg. 86-94
|
Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 495
|
Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 496
|
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
|
Nov/Dec 2017
Pg. 500-512
|
Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori
Mah Xian-Jun, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David
|
Jul/Aug 2017
Pg. 330-333
|
Furosemide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 148
|
Nifedipine 0.5% Rectal Ointment
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 63
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 66-75
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 76-82
|
Calculations
Stockton Shelly J
|
Sep/Oct 2016
Pg. 405
|
Sodium Phosphate Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 413
|
Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 318
|
Mebendazole 100-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 320
|
Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 321
|
Aprepitant 80-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 48
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment
Hecq Jean-Daniel, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Nov/Dec 2015
Pg. 521-524
|
Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 247
|
Dexpanthenol 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 410
|
Barium Sulfate Suspension
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 323
|
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation
Phan Ha, DeReese Annie, Day A J, Carvalho Maria
|
May/Jun 2014
Pg. 203-207
|
Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 233
|
Secretin 4 mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 148
|
Sincalide 1-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 150
|
Droperidol 2.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 62
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 418
|
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
|
Mar/Apr 2013
Pg. 113-123
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 72
|
Stability of Ursodiol in SyrSpend SF Cherry Flavored
Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
|
Nov/Dec 2012
Pg. 510-512
|
Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
|
Jul/Aug 2012
Pg. 276-286
|
Diphenhydramine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 334
|
Ondansetron Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 339
|
Famotidine 10-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 242
|
Metoclopramide 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 243
|
Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 246
|
Ranitidine 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 247
|
Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 163
|
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Zur Eyal
|
Mar/Apr 2012
Pg. 117-124
|
Glycopyrrolate 0.2-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 159
|
Lorazepam 4-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 161
|
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
|
Mar/Apr 2012
Pg. 164-166
|
Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 506
|
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 504
|
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 419
|
Rebamipide Rectal Enema Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 424
|
Ursodiol 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 427
|
Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 336
|
Hydrocortisone 100-mg/60-mL Retention Enema
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 338
|
Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy
Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola
|
May/Jun 2011
Pg. 214-217
|
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay, Williams LaVonn A
|
Mar/Apr 2011
Pg. 124-128
|
Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 156
|
Levamisole 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 161
|
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes
McCluskey Susan V, Lovely Jenna K
|
Mar/Apr 2011
Pg. 170-173
|
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Meadows Richard L, Muller George
|
Sep/Oct 2010
Pg. 382-394
|
Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
|
Jul/Aug 2010
Pg. 276-282
|
Cohen's Rectal Ointment
Allen Loyd V Jr
|
May/Jun 2010
Pg. 244
|
Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 246
|
Rifaximin 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 247
|
Sunitinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 248
|
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
|
Mar/Apr 2010
Pg. 171-173
|
Metronidazole in Normal Saline Enema
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 69
|
Nitroglycerin 4-mg Suppository
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 436
|
Chemical Stability of Scopolamine Hydrobromide Nasal Solution
Gupta Vishnu D
|
Sep/Oct 2009
Pg. 438-439
|
Dexamethasone and Furosemide Injection
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 335
|
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers
Young Jennifer L, Bogner Robin H
|
May/Jun 2009
Pg. 214-217
|
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Muller George
|
May/Jun 2009
Pg. 220-221
|
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding
Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
|
May/Jun 2009
Pg. 250-253
|
Lidocaine 2% Popsicle
Allen Loyd V Jr
|
May/Jun 2009
Pg. 242
|
Aprepitant 20-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 153
|
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 157
|
Nicotine Rectal Enema
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 158
|
Tolterodine 2-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 160
|
Compounding with Sucralfate for the Treatment of External Wounds
Wynn Tom, Williams LaVonn A
|
Jan/Feb 2009
Pg. 25-29
|
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
|
Jan/Feb 2009
Pg. 78-80
|
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
|
Sep/Oct 2008
Pg. 460-462
|
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
|
Jul/Aug 2008
Pg. 372-374
|
Vitamin A Suppository
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 363
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Jul/Aug 2008
Pg. 368-371
|
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Allen Loyd V Jr
|
May/Jun 2008
Pg. 267
|
Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Bassani August S, Banov Daniel, Lehman Paul A
|
May/Jun 2008
Pg. 270-273
|
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 156-160
|
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 170-173
|
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007
Pg. 520-524
|
Rabbit Medicine
Jordan Dinah G
|
Sep/Oct 2007
Pg. 364-374
|
Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 245
|
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids
Vail Jane
|
May/Jun 2007
Pg. 194-199
|
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 158
|
Ranitidine Hydrochloride 15-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 161
|
Tegaserod Meleate 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 162
|
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Fields Shannon W
|
Jan/Feb 2007
Pg. 26-27
|
Lansoprazole 3-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 74
|
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Jan/Feb 2007
Pg. 82-85
|
Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard)
Benischek Rita L, Riffell Gregory S, Mauldin Todd
|
Nov/Dec 2006
Pg. 426-427
|
Famotidine 8-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 382
|
Omeprazole 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 389
|
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 390
|
Pantoprazole Sodium 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 391
|
Hospice Symptom Relief Kit: An Update
Petrin Ronald L
|
Jul/Aug 2006
Pg. 288-290
|
Probiotic Therapy, Part 2: Clinical Perspectives
Vail Jane
|
May/Jun 2006
Pg. 195-200
|
Granisetron 0.05-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 222
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration
Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
|
May/Jun 2006
Pg. 234-236
|
Cimetidine 60-mg/mL Oral Liquid, Alcohol Free
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 139
|
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis
Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
|
Mar/Apr 2006
Pg. 147-153
|
Hospice from a Compounding Pharmacist's Perspective
Jones Marty
|
Mar/Apr 2006
Pg. 89-93
|
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
|
Mar/Apr 2006
Pg. 95-98
|
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Vail Jane
|
Mar/Apr 2006
Pg. 107-111
|
Domperidone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 61
|
Mercaptopurine 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 64
|
Dolasetron 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 475
|
Ursodiol 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 480
|
Formulating for the Gluten-sensitive Individual
Cacace Janice L
|
Sep/Oct 2005
Pg. 357-358
View Sample |
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules
Allen Loyd V Jr
|
Sep/Oct 2005
Pg. 386
|
Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 2005
Pg. 389
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration
Trissel Lawrence A, Zhang Yanping
|
Jul/Aug 2005
Pg. 320-322
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration
Trissel Lawrence A, Xu Quanyun A
|
May/Jun 2005
Pg. 235-237
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Trissel Lawrence A, Xu Quanyun A
|
May/Jun 2005
Pg. 238-241
|
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
|
May/Jun 2005
Pg. 242-246
|
Book Review: Bacteria for Breakfast: Probiotics for Good Health
Reed-Kane Dana
|
Mar/Apr 2005
Pg. 93
|
Homatropine 3-mg Rapid Dissolving Tablets
Allen Loyd V Jr
|
Mar/Apr 2005
Pg. 151
|
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities
Collier Kathleen, Beard Janet
|
Mar/Apr 2005
Pg. 111-115
|
Use of Domperidone as a Prokinetic and Antiemetic
Albright Lisa M
|
Mar/Apr 2005
Pg. 120-125
View Sample |
Phenol 8% Injection
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 69
|
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature
Gupta Vishnu D
|
Jan/Feb 2005
Pg. 72-74
|
BAD (Benadryl, Ativan, and Decadron) Intravenous Drip
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 469
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Sulfasalazine 250-mg/5-mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 474
|
Vancomycin HCl 50-mg/mL Oral Solution
Allen Loyd V Jr
|
Jan/Feb 2003
Pg. 64
|
| Return to Top |
